Zero Candida Begins Prototype Production of Revolutionary ZC-001 Device for Women's Health Zero Candida Technologies has initiated prototype production of ZC-001, an innovative therapeutic device for treating Vulvo-Vaginal Candidiasis, a common condition affecting many women.

Zero Candida Begins Prototype Production of Revolutionary ZC-001 Device for Women's Health #Canada #Vancouver #Zero_Candida #Women's_Health #ZC-001

Innovative Femtech Solutions from Zero Candida Technologies Report Progress and Financial Results Zero Candida Technologies shares its financial and operational results for the first half of 2025, highlighting advancements in women's health solutions.

Innovative Femtech Solutions from Zero Candida Technologies Report Progress and Financial Results #Canada #Vancouver #Zero_Candida #FemTech #VVC_Treatment

Zero Candida Technologies Gears Up for Investor Conference with DTC Eligibility Announcement Zero Candida Technologies secures DTC eligibility, enhancing liquidity for investors and preparing for the upcoming virtual investor conference on August 7th, 2025.

Zero Candida Technologies Gears Up for Investor Conference with DTC Eligibility Announcement #Canada #Vancouver #Zero_Candida #FemTech #investor_conference

Zero Candida Begins Trading on OTCQB Market, Expanding Reach in Women's Health Zero Candida Technologies has officially started trading on the OTCQB Market under the ticker symbol ZCTFF, enhancing its presence in women's health.

Zero Candida Begins Trading on OTCQB Market, Expanding Reach in Women's Health #Canada #Vancouver #Zero_Candida #FemTech #VVC_Treatment

Zero Candida Technologies Set to Transform Women's Health Market by 2030 According to Moore Financial Consulting, Zero Candida Technologies is projected to dominate the women's health market, reaching $2 billion by 2030.

Zero Candida Technologies Set to Transform Women's Health Market by 2030 #Canada #Vancouver #Zero_Candida #FemTech #VVC

Zero Candida Plans to Submit Successful FDA Preclinical Studies by Q3 2025 Zero Candida Technologies is set to finalize its preclinical studies by Q3 2025 in preparation for FDA submission, aiming to transform women's health.

Zero Candida Plans to Submit Successful FDA Preclinical Studies by Q3 2025 #Canada #Vancouver #Zero_Candida #FemTech #ZC-1-A

Zero Candida Achieves Milestone with South African Patent for Innovative FemTech Device Israeli FemTech company Zero Candida has secured a South African patent for its groundbreaking ZC-01 device aimed at treating Candida fungus with unprecedented efficacy.

Zero Candida Achieves Milestone with South African Patent for Innovative FemTech Device #Vancouver #Zero_Candida #FemTech #South_Africa #ZC-01

Zero Candida: Revolutionary FemTech Device Set to Transform Women's Health Care on TSX Venture Exchange Zero Candida has announced its debut on the TSX Venture Exchange, introducing an innovative FemTech device for treating Candida infections, promising a new era in women's health.

Zero Candida: Revolutionary FemTech Device Set to Transform Women's Health Care on TSX Venture Exchange #Canada #Vancouver #Zero_Candida #FemTech